You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
港股異動丨石藥集團(1093.HK)大漲近4%領漲恆指 多大行集體唱多
格隆匯 11-07 10:13
格隆匯11月7日丨石藥集團(1093.HK)今日股價明顯走強,現升3.9%領漲恆指成份股,報21.3港元,暫成交3.1億港元,最新總市值1328.3億港元。近期公司股價穩步上升,續創一年多新高。

並且獲多大行集體唱多。安信國際報告稱,石藥集團研發平台構建完善,即將邁入新藥收穫期,予買入評級。光大證券稱,公司新藥管線佈局深厚,研發平台優勢凸顯。高盛則表示,升石藥目標價至25.8港元,料研發可推動長期增長。
此外同為藥品股的今日再度暴漲,一定程度上帶動了行業偏好。復星醫藥、李氏大藥房皆上漲。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account